Detalles de la búsqueda
1.
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.
Lancet Oncol;
24(4): e161-e171, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36990614
2.
DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
J Neurooncol;
157(3): 499-510, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384518
3.
Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
Lancet Oncol;
22(10): e456-e465, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34592195
4.
Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.
Eur Radiol;
31(6): 4114-4129, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33241519
5.
Neurologic Complications of Cranial Radiation Therapy and Strategies to Prevent or Reduce Radiation Toxicity.
Curr Neurol Neurosci Rep;
20(8): 34, 2020 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601844
6.
The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.
J Neurooncol;
138(2): 299-306, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29453679
7.
Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.
J Neurooncol;
124(1): 137-46, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033544
8.
Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.
J Neurooncol;
119(1): 149-58, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24805151
9.
Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastoma.
J Neurooncol;
119(1): 111-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24792644
10.
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.
Neuro Oncol;
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38770568
11.
Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.
Clin Transl Radiat Oncol;
44: 100697, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046107
12.
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Clin Cancer Res;
30(7): 1327-1337, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252427
13.
Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
Cancer;
119(19): 3479-88, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23821555
14.
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials.
Clin Cancer Res;
29(12): 2194-2198, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939557
15.
Dendritic cell vaccine trials in gliomas: Untangling the lines.
Neuro Oncol;
25(10): 1752-1762, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289203
16.
Validation of Predictive Analyses for Interim Decisions in Clinical Trials.
JCO Precis Oncol;
7: e2200606, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36848613
17.
External validation of three prognostic scores for brain metastasis velocity in patients treated with intracranial stereotactic radiotherapy.
Radiother Oncol;
189: 109917, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741344
18.
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity.
Neuro Oncol;
25(6): 1100-1112, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402744
19.
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Neurooncol Adv;
5(1): vdad083, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554224
20.
Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
J Clin Oncol;
41(17): 3160-3171, 2023 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37027809